
Could Allopurinol Be Marfan’s Lifesaver?
One of the priority objectives of research into rare diseases is to develop new treatments, and orphan medicines — which target conditions affecting no more than 5 in 10,000 people in the EU — provide a critical route toward that aim. A collaboration …